Patent Suit Over Dermatology Drug Dismissed

Law360, New York (June 22, 2006, 12:00 AM EDT) -- A federal court in Georgia thwarted an attempt by River’s Edge Pharmaceuticals LLC to move in on the market for Nicomide, dismissing a lawsuit that challenged the validity of the patent covering the drug, which treats inflammatory skin disorders.

“We’re very pleased,” said Dr. D. Geoffrey Shulman, chairman and chief executive of DUSA Pharmaceuticals Inc., which, along with subsidiary Sirius Laboratories Inc., was targeted by the suit.

“There was no justification in the first place,” Shulman said of the lawsuit in Georgia. “The judge recognized that...
To view the full article, register now.